NCT05977907 · Interventional trial
Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Overall registry status Active not recruiting
Phase 2
Conditions Head and Neck Squamous Cell Carcinoma
Delaware Valley sites
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory